Evidence map›Paper›PMID 30078706›Full record

ArticleCell2018

Dual Roles of Poly(dA:dT) Tracts in Replication Initiation and Fork Collapse.

Anthony Tubbs, Sriram Sridharan, Niek van Wietmarschen, Yaakov Maman, Elsa Callen, Andre Stanlie, Wei Wu, Xia Wu, Amanda Day, Nancy Wong and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 134 papers.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed
44.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 224 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 2 countries.

Anthony TubbsLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Sriram SridharanLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Niek van WietmarschenLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Yaakov MamanLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Elsa CallenLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Andre StanlieLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Wei WuLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Xia WuIBENS, Département de Biologie, Ecole Normale Supérieure, CNRS, Inserm, PSL Research University, 75005 Paris, France.
Amanda DayLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Nancy WongLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Mianmian YinGenetics Branch, National Cancer Institute, NIH, Bethesda, MD, USA.
Andres CanelaLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Haiqing FuDevelopmental Therapeutics Branch and Laboratory of Molecular Pharmacology, NIH, Bethesda, MD, USA.
Christophe RedonDevelopmental Therapeutics Branch and Laboratory of Molecular Pharmacology, NIH, Bethesda, MD, USA.
Steven C PruittDepartment of Molecular and Cellular Biology, Roswell Park Cancer Institute, Buffalo, NY, USA.
Yan JaszczyszynInstitute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette, France.
Mirit I AladjemDevelopmental Therapeutics Branch and Laboratory of Molecular Pharmacology, NIH, Bethesda, MD, USA.
Peter D AplanGenetics Branch, National Cancer Institute, NIH, Bethesda, MD, USA.
Olivier HyrienIBENS, Département de Biologie, Ecole Normale Supérieure, CNRS, Inserm, PSL Research University, 75005 Paris, France.
André NussenzweigLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA. Electronic address: andre_nussenzweig@nih.gov.
National Human Genome Research Institute · USNational Institutes of Health · USCentre National de la Recherche Scientifique · FRNational Cancer Institute · USRoswell Park Comprehensive Cancer Center · USUniversité Paris-Sud · FR

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dean G. Tang · 1985 to 2026
$116.6M
DNA RepairZIABC010283 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSENZWEIG, ANDRE A. · 2009 to 2025
$27.0M
Relationship between DNA damage detection and signalingZIABC010959 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSENZWEIG, ANDRE A. · 2009 to 2025
$27.0M
Intramural NIH HHS ZIA BC010283Intramural NIH HHS ZIA BC010959NCI NIH HHS P30 CA016056
6 · The paper itself

Abstract

Replication origins, fragile sites, and rDNA have been implicated as sources of chromosomal instability. However, the defining genomic features of replication origins and fragile sites are among the least understood elements of eukaryote genomes. Here, we map sites of replication initiation and breakage in primary cells at high resolution. We find that replication initiates between transcribed genes within nucleosome-depleted structures established by long asymmetrical poly(dA:dT) tracts flanking the initiation site. Paradoxically, long (>20 bp) (dA:dT) tracts are also preferential sites of polar replication fork stalling and collapse within early-replicating fragile sites (ERFSs) and late-replicating common fragile sites (CFSs) and at the rDNA replication fork barrier. Poly(dA:dT) sequences are fragile because long single-strand poly(dA) stretches at the replication fork are unprotected by the replication protein A (RPA). We propose that the evolutionary expansion of poly(dA:dT) tracts in eukaryotic genomes promotes replication initiation, but at the cost of chromosome fragility.

Indexed as

DNA ReplicationReplication OriginAmino Acid MotifsAnimalsCell LineChromatin ImmunoprecipitationChromosomal InstabilityChromosome Fragile SitesChromosome FragilityDNA, RibosomalFemaleMaleMiceMice, Inbred C57BLNucleosomesPoly dA-dTDNA, RibosomalNucleosomesPoly dA-dTDNA breaksfragile sitesgenome instabilitypoly(dA:dT) tractsreplication fork barrierreplication originsreplication stressribosomal DNA

Identifiers

PMID30078706
PMCPMC6591735
OpenAlexW2886241640

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.